---
title: "Keyence surges 16% to hit daily limit after strong earnings and buyback announcement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284151284.md"
description: "Keyence (KYCCF) surged 16% on Monday, marking its largest gain since August 2024, following a quarterly operating income that surpassed analyst expectations. The company announced plans to seek investor approval for charter amendments to facilitate stock buybacks, leading to the stock hitting its daily limit."
datetime: "2026-04-27T04:15:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284151284.md)
  - [en](https://longbridge.com/en/news/284151284.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284151284.md)
generator: "portal-rs"
---

# Keyence surges 16% to hit daily limit after strong earnings and buyback announcement

Keyence (KYCCF) jumped 16% on Monday, the biggest gain since August 2024, after the Japanese maker of factory automation sensors delivered quarterly operating income that exceeded analyst estimates. The comany also said it will seek investor approval to amend its charter to enable buybacks. The stock reached the daily limit after operating profit f...

### Related Stocks

- [6861.JP](https://longbridge.com/en/quote/6861.JP.md)
- [KYCCF.US](https://longbridge.com/en/quote/KYCCF.US.md)

## Related News & Research

- [Keyence Corporation Just Beat EPS By 24%: Here's What Analysts Think Will Happen Next](https://longbridge.com/en/news/294426416.md)
- [Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)](https://longbridge.com/en/news/296009371.md)
- [Abivax SA Sponsored ADR $ABVX Shares Sold by Royal Bank of Canada](https://longbridge.com/en/news/296326332.md)
- [Arkema: Disclosure of Trading in Own Shares from 10 August to 14 August 2026](https://longbridge.com/en/news/296200311.md)
- [Citi Appointed as Depositary Bank for Agilyx ASA's ADR Program | C Stock News](https://longbridge.com/en/news/296578896.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**